High chylomicron remnant causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]

Overview

High chylomicron remnants level can either be due to genetic conditions as in type I and type V hyperlipoproteinemia or can be secondary to conditions such as chronic renal failure, hypothyroidism, and diabetes mellitus.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Acute renal failure

Common Causes

Causes by Organ System

Cardiovascular	No underlying causes
Chemical/Poisoning	No underlying causes
Dental	No underlying causes
Dermatologic	No underlying causes
Drug Side Effect	Antiretroviral therapy, atypical antipsychotics, glucocorticoids, heparin, isotretinoin, oral contraceptives, tamoxifen, thiazide diuretics
Ear Nose Throat	No underlying causes
Endocrine	Diabetes mellitus, hypothyroidism
Environmental	No underlying causes
Gastroenterologic	Acute pancreatitis, alcoholic liver disease, cirrhosis, hepatitis, hereditary hemochromatosis, non-alcoholic steatohepatitis (NASH), Wilson’s disease
Genetic	Familial hypertriglyceridemia, fructose-1-phosphate aldolase deficiency, galactosemia, glycogen storage disease type I, glycogen storage disease type IV, lipoprotein lipase deficiency, mixed hyperlipoproteinemia, type 1C hyperlipoproteinemia, tyrosinemia type 1
Hematologic	No underlying causes
Iatrogenic	Dialysis
Infectious Disease	No underlying causes
Musculoskeletal/Orthopedic	No underlying causes
Neurologic	No underlying causes
Nutritional/Metabolic	Familial hypertriglyceridemia, glycogen storage disease type I, glycogen storage disease type IV, high carbohydrate diet, high saturated fat diet, isolated low HDL, lipoprotein lipase deficiency
Obstetric/Gynecologic	Pregnancy
Oncologic	No underlying causes
Ophthalmologic	No underlying causes
Overdose/Toxicity	No underlying causes
Psychiatric	No underlying causes
Pulmonary	No underlying causes
Renal/Electrolyte	Acute renal failure, chronic renal failure, nephrotic syndrome
Rheumatology/Immunology/Allergy	Autoimmune hyperchylomicronemia ^[1]
Sexual	No underlying causes
Trauma	No underlying causes
Urologic	No underlying causes
Miscellaneous	Alcoholism

Causes by Alphabetical Order

References

↑ ^1.0 ^1.1 Yoshimura, T.; Ito, M.; Sakoda, Y.; Kobori, S.; Okamura, H. (1998). “Rare case of autoimmune hyperchylomicronemia during pregnancy”. Eur J Obstet Gynecol Reprod Biol. 76 (1): 49–51. PMID 9481547. Unknown parameter |month= ignored (help)
↑ Weintraub M, Burstein A, Rassin T, Liron M, Ringel Y, Cabili S; et al. (1992). “Severe defect in clearing postprandial chylomicron remnants in dialysis patients”. Kidney Int. 42 (5): 1247–52. PMID 1453610.
↑ Ito M, Takamatsu J, Matsuo T, Kameoka K, Kubota S, Fukata S; et al. (2003). “Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement”. Clin Endocrinol (Oxf). 58 (5): 621–6. PMID 12699445.
↑ Benjó AM, Maranhão RC, Coimbra SR, Andrade AC, Favarato D, Molina MS; et al. (2006). “Accumulation of chylomicron remnants and impaired vascular reactivity occur in subjects with isolated low HDL cholesterol: effects of niacin treatment”. Atherosclerosis. 187 (1): 116–22. doi:10.1016/j.atherosclerosis.2005.08.025. PMID 16458316.
↑ Brasaemle DL, Cornely-Moss K, Bensadoun A (1993). “Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E.” J Lipid Res. 34 (3): 455–65. PMID 8468529.

[Yoshimura-1998-1] 1.0 ^1.1 Yoshimura, T.; Ito, M.; Sakoda, Y.; Kobori, S.; Okamura, H. (1998). “Rare case of autoimmune hyperchylomicronemia during pregnancy”. Eur J Obstet Gynecol Reprod Biol. 76 (1): 49–51. PMID 9481547. Unknown parameter |month= ignored (help)

[pmid1453610-2] Weintraub M, Burstein A, Rassin T, Liron M, Ringel Y, Cabili S; et al. (1992). “Severe defect in clearing postprandial chylomicron remnants in dialysis patients”. Kidney Int. 42 (5): 1247–52. PMID 1453610.

[pmid12699445-3] Ito M, Takamatsu J, Matsuo T, Kameoka K, Kubota S, Fukata S; et al. (2003). “Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement”. Clin Endocrinol (Oxf). 58 (5): 621–6. PMID 12699445.

[pmid16458316-4] Benjó AM, Maranhão RC, Coimbra SR, Andrade AC, Favarato D, Molina MS; et al. (2006). “Accumulation of chylomicron remnants and impaired vascular reactivity occur in subjects with isolated low HDL cholesterol: effects of niacin treatment”. Atherosclerosis. 187 (1): 116–22. doi:10.1016/j.atherosclerosis.2005.08.025. PMID 16458316.

[pmid8468529-5] Brasaemle DL, Cornely-Moss K, Bensadoun A (1993). “Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E.” J Lipid Res. 34 (3): 455–65. PMID 8468529.

[1]

[2]

[3]

[4]

[5]